Position in CRDF
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$430,813
-$1,492,041 QoQ
Shares Held
331,395
-72.1% QoQ
Ownership
0.426%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 104 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. CRDF ranks #306 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in CRDF
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $430,813 | 331,395 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,922,854 | 1,186,947 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,348,528 | 1,191,647 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,361,499 | 1,146,359 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,548,556 | 1,126,526 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,952,491 | 940,284 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,682,832 | 848,579 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,223,180 | 832,652 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,787,153 | 805,024 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $747,306 | 139,945 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $207,118 | 139,945 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $194,523 | 139,945 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $205,719 | 139,945 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $230,909 | 139,945 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $195,923 | 139,945 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $215,515 | 139,945 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $307,879 | 139,945 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,746,507 | 704,237 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,167,604 | 693,445 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,206,162 | 631,556 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,288,365 | 494,491 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $101,452 | 10,956 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $45,852,408 | 2,548,772 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||